Skip to main content
Equibles
BLFS logo

BLFS · Biolife Solutions Inc

Track BLFS — free

Use BLFS with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$35.25 -0.28 (-0.79%) At close · Sep 4
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$1.72B
Shares
48.91M

BLFS metrics

68 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$35.25
Market cap
$1.72B

Price action

19 metrics
Price change (1W)
-3.1%
Price change (30D)
+1.8%
Price change (3M)
+32.3%
Price change (6M)
+77.5%
Price change (YTD)
+45.8%
Price change (1Y)
+36.3%
Trailing year
Price change (5Y)
-33.8%
52-week high
$37.22
52-week low
$18.15
Change from 52-week high
-5.3%
Change from 52-week low
+94.2%
Annualized volatility
43.7%
Beta
1.2
RSI (14D)
53.1
Price vs SMA 50
+8.8%
Price vs SMA 200
+38.5%
Avg volume (3M)
1.09M
Relative volume
0.3
Average dollar volume
$33.70M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
48.91M

Valuation

12 metrics
P / E (TTM)
30.4
Trailing earnings · reciprocal yield 3.3%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
16.2×
reciprocal yield 6.2%
P / book
4.1
reciprocal yield 24.4%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
102.1
reciprocal yield 1.0%
Earnings yield
3.4%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
9.3×
reciprocal yield 10.8%
EV / revenue historical average (5Y)
9.4×
reciprocal yield 10.6%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
64.6%
Operating margin
1.6%
Trailing 12 months
Net margin
54.3%
Gross profit (TTM)
$67.87M
Operating profit (TTM)
$1.75M
Net income (TTM)
$57.98M
Trailing 12 months
Diluted EPS (TTM)
$1.16
FCF margin
—
Effective tax rate
-620.5%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-0.14

Growth

11 metrics
Revenue growth YoY
+21.5%
Year over year
Net income growth YoY
—
Revenue (TTM)
$106.69M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+3.1%
Year over year · more shares
Revenue CAGR (3Y)
+8.1%
Revenue CAGR (5Y)
+14.9%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
+17.8%

Quality

14 metrics
Return on equity
13.8%
Return on assets
13.0%
Debt / equity
0.0
Current ratio
9.7
EBITDA (TTM)
$3.43M
Free cash flow (TTM)
—
Quick ratio
7.1
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$24.00M
Total assets
$447.49M
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$16.88M
Capital expenditures (TTM)
$8.77M
R&D (TTM)
$9.77M
SG&A (TTM)
—
Stock compensation (TTM)
$21.64M
R&D / revenue
9.2%
Stock compensation / revenue
20.3%

Ownership (13F)

3 metrics
13F filers
216
13F filer change QoQ
+28
Institutional ownership
101.1%

Short interest

3 metrics
Short interest
8.2%
Latest settlement · 7.8 days to cover
Days to cover
7.8d
Short-squeeze score
76 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 834365 CUSIP 09062W204 13F (30d) 135 filings 135 filers Visit website